← Every applicant
Ajanta Pharma Ltd FDA Approvals
28 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| HALOPERIDOLNew drugSep 14, 2026TABLET, ORAL |
| IVERMECTINNew drugApr 7, 2026TABLET, ORAL |
| DAPAGLIFLOZINNew drugApr 6, 2026TABLET, ORAL |
| METHAZOLAMIDENew drugFeb 9, 2026TABLET, ORAL |
| PRUCALOPRIDE SUCCINATENew drugJan 16, 2026TABLET, ORAL |
| TOPIRAMATENew drugSep 2, 2025CAPSULE, EXTENDED RELEASE, ORAL |
| TOFACITINIB CITRATENew drugAug 19, 2025TABLET, EXTENDED RELEASE, ORAL |
| TERAZOSIN HYDROCHLORIDENew drugMay 12, 2025CAPSULE, ORAL |
| THEOPHYLLINENew drugJan 13, 2025TABLET, EXTENDED RELEASE, ORAL |
| FLUVOXAMINE MALEATENew drugOct 17, 2024CAPSULE, EXTENDED RELEASE, ORAL |
| DOXEPIN HYDROCHLORIDENew drugJul 1, 2024TABLET, ORAL |
| PALIPERIDONENew drugJun 26, 2024TABLET, EXTENDED RELEASE, ORAL |
| PROCHLORPERAZINE MALEATENew drugMay 9, 2024TABLET, ORAL |
| VARENICLINE TARTRATENew drugMar 19, 2024TABLET, ORAL |
| OXCARBAZEPINENew drugFeb 22, 2024TABLET, EXTENDED RELEASE, ORAL |
| FAMOTIDINENew drugSep 18, 2023FOR SUSPENSION, ORAL |
| ACETAZOLAMIDENew drugSep 11, 2023TABLET, ORAL |
| TOPIRAMATENew drugAug 15, 2023CAPSULE, EXTENDED RELEASE, ORAL |
| GUANFACINE HYDROCHLORIDENew drugApr 27, 2023TABLET, ORAL |
| VENLAFAXINE HYDROCHLORIDENew drugApr 12, 2023TABLET, EXTENDED RELEASE, ORAL |
| CARBAMAZEPINENew drugMar 24, 2023TABLET, EXTENDED RELEASE, ORAL |
| PANTOPRAZOLE SODIUMNew drugFeb 9, 2023FOR SUSPENSION, DELAYED RELEASE, ORAL |
| BREXPIPRAZOLENew drugFeb 3, 2023TABLET, ORAL |
| FLUPHENAZINE HYDROCHLORIDENew drugJan 5, 2023TABLET, ORAL |
| NAPROXEN AND ESOMEPRAZOLE MAGNESIUMNew drugOct 6, 2022TABLET, DELAYED RELEASE, ORAL |
| TOFACITINIB CITRATENew drugJun 1, 2021TABLET, ORAL |
| METFORMIN HYDROCHLORIDENew drugMar 9, 2021TABLET, EXTENDED RELEASE, ORAL |
| LAMOTRIGINENew drugJan 19, 2021TABLET, ORALLY DISINTEGRATING, ORAL |